Praxis Precision Medicine Analyst Price Targets

Wall Street analyst price targets and consensus rating for Praxis Precision Medicine (PRAX).

Price Target Range — 10 Quarters

Analyst Consensus — 17 Analysts

16Buy

1Sell

Consensus RatingBuy# Analysts17Avg. Consensus PT$539Upside to Avg. PT+92.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 6, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$1201
Oct 6, 2026	BTIG	Kambiz Yazdi	PT Raise	Buy	$810→$826
Sep 24, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$1201
Sep 24, 2026	Needham	Ami Fadia	Maintained	Buy	$582
Aug 21, 2026	Goldman Sachs	Kevin Strang	PT Raise	Buy	$470→$575
Aug 7, 2026	RBC Capital	Leonid Timashev	PT Raise	Outperform	$449→$462
Aug 7, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Equal-Weight	$323→$362
Aug 6, 2026	Needham	Ami Fadia	PT Raise	Buy	$575→$582
Jul 29, 2026	BTIG	Kambiz Yazdi	Maintained	Buy	$810
Jul 13, 2026	Goldman Sachs	Kevin Strang	Initiate	Buy	$447
Jun 29, 2026	Needham	Ami Fadia	PT Raise	Buy	$537→$575
Jun 18, 2026	RBC Capital	Leonid Timashev	Initiate	Outperform	$449
Jun 2, 2026	Oppenheimer	Jay Olson	PT Cut	Outperform	$750→$650
Jun 2, 2026	Truist Securities	Danielle Brill	PT Cut	Buy	$715→$616
Jun 2, 2026	Deutsche Bank	David Hoang	PT Cut	Buy	$420→$374
Jun 2, 2026	Wedbush	Laura Chico	PT Cut	Underperform	$166→$162
Jun 2, 2026	Baird	Joel Beatty	PT Cut	Outperform	$433→$400
Jun 2, 2026	HC Wainwright & Co.	Douglas Tsao	PT Cut	Buy	$1245→$1201
Jun 2, 2026	BTIG	Kambiz Yazdi	PT Cut	Buy	$843→$810
May 26, 2026	HC Wainwright & Co.	Douglas Tsao	Maintained	Buy	$1245

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $1201 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $810 to $826.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $1201 price target.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $582 price target.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $449 to $462.

Benzinga Newsdesk

Praxis Precision Medicines Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Praxis Precision Medicine Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

PRO
BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

PRO
Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

PRO
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

PRO
RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

People Also Watch

People Also Watch

Praxis Precision Medicines Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Praxis Precision Medicine Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

PROBTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

PROHC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

PRONeedham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

PROGoldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

PRORBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

PRO
BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

PRO
Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

PRO
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

PRO
RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462